1Misawa S, Kumagai I.Refolding of therapeutic proteins produced in Escherichia coli as inclusion bodies [J]. Biopolymers, 1999,51 : 297- 307.
2Hlodan R, Craig S, Pain R H.Protein folding and its implications for the production of recombinant proteins [ J ].Biotech Genet Eng Rev, 1991,9: 47- 88.
3De Bemardez Clark E.Protein refolding for industrial process [J].Current Opinion in Biotechnology, 2001,12: 202 -207.
4Patra A K, Mukhopadhyay R,Mukhija R, et al.Optimization of inclusion body solubilization and renaturation of recombinant human growth hormone from Escherichia coli [ J ] .Protein Expr Purif, 2000, 18: 182-192.
5Guise A D, West S M, Chaudhuri J B.Protein folding in vivo and renaturation of recombinant proteins from inclusion bodies [ J ].Mol Biotech, 1996,6 ( 1 ):53-64.
6Dabora J M, Sanyal G, Middaugh C R.Effect ofpolyanion on the refolding of human acidic fibroblast growth factor. [J]. J Biol Chem, 1991,266(35 ):23637-23640.
7Builder S, Hart R, Lester P, et al.Refolding of misfolded insulin-like growth factor-Ⅰ [ J ]. US patent, 1997,663( 1 ): 304.
